growth/size/body
| N |
• normal development and no macroscopic or histological abnormalities in major organs
|
homeostasis/metabolism
| N |
• no albuminuria at age 2 or 12 months
|
albuminuria
(
J:293292
)
|
• from 5 weeks after induction of diabetes with streptozotocin (STZ)
• no albuminuria at age 2 or 12 months
|
mortality/aging
| N |
• mice born at normal Mendelian ratio
|
renal/urinary system
| N |
• normal renal histology at birth and at age 2 months
• normal tubulointerstitial morphology at age 12 months
|
albuminuria
(
J:293292
)
|
• from 5 weeks after induction of diabetes with streptozotocin (STZ)
• no albuminuria at age 2 or 12 months
|
|
• focal segmental foot process effacement 24 weeks after induction of diabetes with streptozotocin (STZ)
|
|
• at age 12 months
|
|
• at age 12 months
• more prominent 24 weeks after induction of diabetes with streptozotocin (STZ) then in WT
• normal renal histology at birth and at age 2 months
|
|
• focal segmental glomerulosclerosis (FSGS) as well as complete sclerosis 24 weeks after induction of diabetes with streptozotocin (STZ)
|


Analysis Tools